Commentary. Reflections in a crystal ball.
作者信息
Lasagna L
出版信息
Clin Pharmacol Ther. 1975 Jul;18(1):1-8. doi: 10.1002/cpt19751811.
PMID:1097147
Abstract
摘要
相似文献
1
Commentary. Reflections in a crystal ball.评论。对未来的展望。
Clin Pharmacol Ther. 1975 Jul;18(1):1-8. doi: 10.1002/cpt19751811.
2
The art and science of contemporary drug development.
Prog Drug Res. 1972;16:194-210. doi: 10.1007/978-3-0348-7081-8_4.
3
Prescriptions enter the political arena.处方进入了政治舞台。
J Leg Med (N Y). 1974 Mar-Apr;2(2):24-30.
4
Drug bioequivalence. Recommendations from the Drug Bioequivalence Study Panel to the Office of Technology Assessment, Congress of the United States.药物生物等效性。药物生物等效性研究小组给美国国会技术评估办公室的建议。
J Pharmacokinet Biopharm. 1974 Oct;2(5):433-66.
5
Knowledge is power: legislative control of drug industry trade secrets.
Spec Law Dig Health Care (Mon). 1987 May;8(15):7-31.
6
Impact of the US FDA "Biopharmaceutics Classification System" (BCS) Guidance on Global Drug Development.美国 FDA“生物药剂学分类系统”（BCS）指导原则对全球药物开发的影响。
Mol Pharm. 2017 Dec 4;14(12):4334-4338. doi: 10.1021/acs.molpharmaceut.7b00687. Epub 2017 Nov 7.
7
Issues in clinical trial design from the FDA perspective.从美国食品药品监督管理局的角度看临床试验设计中的问题。
Epilepsia. 2003;44 Suppl 7:9-15. doi: 10.1046/j.1528-1157.44.s7.7.x.
8
Clinical trials of drugs from the viewpoint of the Food and Drug Administration.
Clin Pharmacol Ther. 1975 Nov;18(5 Pt 2):634-6. doi: 10.1002/cpt1975185part2634.
9
In drug research, some guinea pigs are now human.在药物研究中，现在有些豚鼠就是人类。
N Y Times Web. 2004 Aug 4:A1, C3.
10
Bioequivalence/bioavailability retention samples.
Qual Assur. 1993 Mar-Jun;2(1-2):42-3.
Zotero 插件